Watchlist Price Alert

AEON Biopharma Inc. (AEON)

NASDAQ: AEON · Real-Time Price · USD

0.46

-0.02 (-4.15%)

At close: May 08, 2025, 3:59 PM

0.46

0.15%

Pre-market: May 09, 2025, 04:54 AM EDT

-4.15% (1D)

Bid	0.45
Market Cap	4.82M
Revenue (ttm)	n/a
Net Income (ttm)	42.01M
EPS (ttm)	5250.96
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	Buy

Ask	0.47
Volume	190,093
Avg. Volume (20D)	3,221,442
Open	0.47
Previous Close	0.48
Day's Range	0.43 - 0.48
52-Week Range	0.38 - 269.28
Beta	0.38

About AEON

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AEON

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AEON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 months ago

-43.29%

AEON Biopharma shares are trading lower after the ... Unlock content with Pro Subscription

4 months ago

-63.09%

AEON Biopharma shares are trading lower after the company announced the pricing of a $20 million offering of 40 million units at $0.50 per unit.

News

8 months ago · zacks.com

AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

AEON Biopharma, Inc. (AEON) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions cou...

11 months ago · zacks.com

Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround

AEON Biopharma, Inc. (AEON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts ...

12 months ago · zacks.com

AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AEON Biopharma, Inc. (AEON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earning...

1 year ago · zacks.com

Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now

After losing some value lately, a hammer chart pattern has been formed for AEON Biopharma, Inc. (AEON), indicating that the stock has found support. This, combined with an upward trend in earnings est...